XML 60 R47.htm IDEA: XBRL DOCUMENT v3.25.4
Stockholders' Equity (Tables)
 12 Months Ended
Dec. 31, 2025
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Share-based Payment Arrangement, Activity
Performance award activity is as follows (in thousands, except shares):
Years Ended December 31,
202520242023
SharesFair ValueSharesFair ValueSharesFair Value
Granted90,894 $3,508 — $— — $— 
Returned for payroll taxes
142,070 $5,662 — $— — $— 
Cancelled58,013 $2,423 80,276 $871 54,229 $1,565 
Common stock activity is as follows (in thousands, except shares):
Years Ended December 31,
202520242023
SharesFair ValueSharesFair ValueSharesFair Value
Granted(1)
— $— — $— 30,000 $826 
Returned for payroll taxes— $— — $— 1,001 $28 
(1)
During the year ended December 31, 2023, we issued 30,000 shares of common stock to a former executive at a stock price of $27.54, in accordance with his Separation and Release Agreement pertaining to his resignation from his position as the Company’s Executive Vice President, Chief Financial Officer & Treasurer effective January 2, 2023.
Common stock issued to certain employees under this incentive program is as follows (in thousands, except shares):
Years Ended December 31,
202520242023
SharesFair ValueSharesFair ValueSharesFair Value
11,958 $497 31,470 $790 8,444 $276 
(1)
Common stock granted during the year ended December 31, 2025, 2024, and 2023 had a grant date stock price of $41.54, $25.08, and $32.69, respectively.
Schedule of Share-based Compensation, Stock Options, Activity
Stock option grants and cancellations are as follows (in thousands, except shares):
Years Ended December 31,
202520242023
SharesFair ValueSharesFair ValueSharesFair Value
Granted(1)
— $— 370,590 $3,830 214,191 $2,506 
Cancelled22,190 $273 532,266 $6,311 105,150 $1,380 
(1)
Stock options granted during the years ended December 31, 2024 and 2023 had a weighted average price of $24.48 and $32.69, respectively. The fair value of these options was calculated using the Black-Scholes option pricing model. The options granted in 2024 and 2023 vest over a three-year period and have a ten-year term.
Additional stock option activity is as follows (in thousands, except shares):
Years Ended December 31,
202520242023
SharesCashSharesCashSharesCash
Exercised(1)
324,497 $584 97,548 $1,439 74,200 N/A
Returned for option price(2)
191,280 $8,547 28,882 $1,113 56,957 $— 
Returned for payroll taxes(3)
34,969 $1,446 4,482 $174 5,486 $174 
(1)
Stock options exercised during the years ended December 31, 2025, 2024, and 2023 had a weighted average exercise price of $27.46, $26.12 and $23.98, respectively.
(2)Represents shares withheld/cash received for the payment of the option price.
(3)Represents shares withheld/cash paid for the payment of payroll taxes.
The fair value of the options granted using the Black-Scholes option pricing model was estimated on the date of grant with the following assumptions:
Years Ended December 31,
20242023
Grant dateFebruary 21February 22
Expected holding period (years)6.04.0
Awards granted370,590214,191
Dividend yield1.79 %1.38 %
Expected volatility43.59 %43.68 %
Risk-free interest rate4.31 %4.27 %
Black-Scholes value$10.34$11.70
A summary of the number of stock options and their weighted average exercise prices during the year ended December 31, 2025 is presented in the table below (shares in thousands): 
SharesWtd. Avg.
Ex. Price
Outstanding at January 11,344 $32.39 
Exercised(324)$27.46 
Forfeited or expired(23)$36.97 
Outstanding at December 31997 $33.89 
Exercisable at December 31556 $34.08 
A summary of the number of stock options and their weighted average grant date fair values during the year ended December 31, 2025 is presented in the table below (shares in thousands): 
SharesWtd. Avg.
Fair Value
Non-vested at January 1727 $11.98 
Vested or exercised(268)$11.35 
Forfeited(18)$11.45 
Non-vested at December 31441 $12.34 
Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range
The following table further describes our outstanding stock options at December 31, 2025:
 Options OutstandingOptions Exercisable
Actual Ranges of Exercise PricesNumber Outstanding at 12/31/25Weighted-Average
Remaining
Contractual Life		Weighted-Average
Exercise Price		Number Exercisable at 12/31/25Weighted-Average
Remaining
Contractual Life		Weighted-Average
Exercise Price
$18.02 - $18.02
13,333 4.48$18.02 13,333 4.48$18.02 
$20.06 - $26.54
353,520 7.10$24.75 145,220 5.61$25.14 
$31.58 - $31.58
12,600 6.74$31.58 12,600 6.74$31.58 
$32.69 - $49.48
617,945 5.88$39.51 385,246 5.77$38.08 
$18.02 - $49.48
997,398 6.31$33.89 556,399 5.72$34.08 
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity
Restricted stock activity is as follows (in thousands, except shares):
Years Ended December 31,
202520242023
SharesFair ValueSharesFair ValueSharesFair Value
Granted(1)
114,684 $4,764 156,630 $3,834 142,020 $4,634 
Returned for payroll taxes28,656 $1,168 16,354 $419 1,473 $50 
Cancelled10,004 $357 55,050 $1,623 1,826 $61 
(1)
Restricted stock granted during the year ended December 31, 2025, 2024 and 2023 will vest over a three-year period, if the employee has remained continuously employed by us during the vesting period, at a weighted average stock price of $41.54, $24.48 and $32.63, respectively.
Restricted stock awardsSharesWeighted Average
Grant Date
Fair Value
Unvested at January 1196,480 $27.01 
Granted 114,684 $41.54 
Vested(75,600)$27.77 
Cancelled(10,004)$35.73 
Unvested at December 31225,560 $33.76 
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable
A summary of the intrinsic value of stock options exercised and the fair value of stock options vested for the three years ended December 31, 2025 is presented in the table below (in thousands): 
Years Ended December 31,
202520242023
Intrinsic value of options exercised$5,053 $647 $538 
Fair value of stock options vested
6,258 5,825 6,003 
Share-based Payment Arrangement, Performance Shares, Outstanding Activity
A summary of the number of performance awards and their weighted average grant date fair values during the year ended December 31, 2025 is presented in the table below: 
Performance AwardsSharesWeighted Average
Grant Date
Fair Value
At January 1297,531 $22.23 
Granted 90,894 $38.59 
Vested(239,518)17.50 
Cancelled(58,013)$41.77 
At December 3190,894 $38.59 
Schedule of Share-based Compensation, Employee Stock Purchase Plan, Activity
ESPP activity is as follows:
Years Ended December 31,
202520242023
SharesPriceSharesPriceSharesPrice
ESPP34,208 $33.09 55,850 $21.26 63,372 $23.58 
Employee Stock Purchase Plan  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions
The fair values of the right to purchase shares under the ESPP are estimated at the date of purchase with the four quarterly purchase dates using the following assumptions:
Years Ended December 31,
202520242023
Dividend yield1.05 %1.51 %1.30 %
Expected volatility28.8 %41.2 %53.5 %
Risk-free interest rate
4.36%, 4.25%, 4.21%, 4.17%
5.46%, 5.24%, 5.02%,4.80%
4.53%, 4.77%, 4.75%, 4.72%
Expected life (years)
0.25, 0.50, 0.75, 1.00
0.25, 0.50, 0.75, 1.00
0.25, 0.50, 0.75, 1.00